Proteins and Peptides

08 Jun 2007 Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
08 Jun 2007 Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
08 Jun 2007 Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
08 Jun 2007 Lipid Sciences Announces Validation of Proprietary Peptide That Mimics Key Functions of Natural Human HDL
06 Jun 2007 Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
05 Jun 2007 Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
05 Jun 2007 SciClone's SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study
05 Jun 2007 ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in
04 Jun 2007 Xanthus announces Phase 1 results for P2045 - a targeted agent for nonsmall cell lung cancer
03 Jun 2007 Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
01 Jun 2007 Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
01 Jun 2007 Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
01 Jun 2007 Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
01 Jun 2007 Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex(TM) (ancrod)
01 Jun 2007 Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
01 Jun 2007 Top line results of phase III study in acute ischemic stroke (DIAS-2) do not demonstrate difference between desmoteplase and placebo
26 May 2007 Mircera receives positive opinion in Europe for the treatment of anaemia due to chronic kidney disease
26 May 2007 Tercica Reports Increlex Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
25 May 2007 Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
24 May 2007 Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
24 May 2007 Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
23 May 2007 Phase 1b insulin clinical trial commenced
23 May 2007 Voraxaze (TM) Update
22 May 2007 Roche receives approvable letter for Mircera in the United States

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up